20435 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
INDAZOLE INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF
#2TREATMENT OF LEISHMANIASIS
#3TREATMENT OF IMMUNOSUPPRESSED SUBJECTS
#4KLRG1 SIGNALLING THERAPY FOR INFECTIOUS DISEASE
#5PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS
#6FUSED BICYCLIC EGFR INHIBITORS AND METHODS OF USE THEREOF
#7METHODS FOR TREATING HEPATOCELLULAR CARCINOMA
#8METHOD OF INHIBITING LIPASE ACTIVITY IN AGING
#9Compounds and Their Use for Treatment of Hemoglobinopathies
#10APOL1 INHIBITORS AND METHODS OF USES THEREOF
#11SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF
#12METHODS FOR THE PROPHYLAXIS AND TREATMENT OF COVID AND COVID-19
#13COMPOSITIONS FOR TREATING AND/OR PREVENTING CELL OR TISSUE NECROSIS SPECIFICALLY TARGETING CATHEPSIN C AND/OR CELA1 AND/OR CELA3A AND/OR STRUCTURALLY RELATED ENZYMES THERETO
#14TREATMENT OF IMMUNOSUPPRESSED SUBJECTS
#15SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF
#16PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION
#17NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING NRF2 ACTIVATION EFFECT
#18CLAUDIN INHIBITORS AND METHODS OF USE THEREOF
#193,4-Dihydroisoquinolin-1(2H)-Ones Derivatives as STING Antagonists and the Use Thereof
#20NOVEL ESTROGEN RECEPTOR MUTATIONS AND USES THEREOF
#21NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING NRF2 ACTIVATION EFFECT
#22PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF
#23SLC26A3 INHIBITORS AND USE THEREOF
#24N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO
#25USE OF ARISTOLOXAZINE C HAVING ANTICANCER ACTIVITY
#26TREATMENT FOR INFLAMMATORY DISEASE
#27Antiviral Therapy
#28FUSED BICYCLIC SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF
#29PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING VIRAL INFECTIOUS DISEASES, CONTAINING EFAVIRENZ AND FLUOXETINE AS ACTIVE INGREDIENTS
#30Treatment of immunosuppressed subjects
#31FLAVONOID DERIVATIVES WITH GABAA RECEPTOR ACTIVITY AND METHODS OF USE
#32NANOPARTICLES AND USES THEREOF FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS
#33FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF
#34METHOD OF TREATING CANCER AND BONE CANCER PAIN
#35CAPSID INHIBITORS FOR THE TREATMENT OF HIV
#36COMPOSITIONS FOR TREATING AND/OR PREVENTING CELL OR TISSUE NECROSIS SPECIFICALLY TARGETING CATHEPSIN C AND/OR CELA1 AND/OR CELA3A AND/OR STRUCTURALLY RELATED ENZYMES THERETO
#37MEDICAMENT FOR PREVENTING AND/OR TREATING DRY EYE
#38PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF
#39"Cyclopenta[c]pyrrol Negative Allosteric Modulators of NR2B"
#40DEUTERATED ANALOGS OF ETIFOXINE AND METHODS OF ADMINISTRATION WITHOUT AUTOINDUCTION OF METABOLISM
#41OIL-IN-WATER EMULSION OF 6-ETHOXY-7-METHOXY-2-(2-METHYLSULFANYLPHENYL)-3,L-BENZOXAZIN-4-ONE
#42ANTIVIRAL JAK INHIBITORS USEFUL IN TREATING OR PREVENTING RETROVIRAL AND OTHER VIRAL INFECTIONS
#43HBV INHIBITOR AND ITS USE
#44Compounds for treating coronavirus infection
#45ALLOSTERIC AKT INHIBITORS FOR USE IN THE TREATMENT OF HEREDITARY HEMORRHAGIC TELANGIECTASIA
#46METHOD FOR AMELIORATING PROGRESSION OF RENAL FIBROSIS AND TREATING RENAL FIBROSIS BY 5-(2',4'-DIFLUOROPHENYL)-SALICYLANILIDE DERIVATIVES
#47Agent For Treating Or Preventing Pancreatic Fistula
#48Treatment of immunosuppressed subjects
#49NANODRUGS FOR TARGETED DRUG DELIVERY AND USE THEREOF
#50ANTI-ERBB2 ANTIBODY-DRUG CONJUGATE AND COMPOSITION THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#51LONG-ACTING THERAPEUTIC AGENT COMBINATIONS AND METHODS THEREOF
#52DEUTERATED ANALOGS OF ETIFOXINE, THEIR DERIVATIVES AND USES THEREOF
#53Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS)
#54PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER CONTAINING ANTIVIRAL AGENT AND ANTIDEPRESSANT AS ACTIVE INGREDIENTS
#55Methods for the prophylaxis and treatment of COVID and COVID-19
#56Method of Treating Cancer and Bone Cancer Pain
#57Process for preparing nano-or microparticles comprising a carrier-polymer and one or more biologically active ingredients
#58USES OF TAXIFOLIN FOR RESPIRATORY HEALTH
#59Medicament for preventing and/or treating dry eye
#60SUBSTITUTED NUCLEOSIDE ANALOGS AS PRMT5 INHIBITORS
#61COMBINATION THERAPY USING A CHEMOKINE RECEPTOR 2 (CCR2) ANTAGONIST AND A PD-1/PD-L1 INHIBITOR
#62COMPOSITION FOR TREATING SYNUCLEINOPATHIES
#63METHODS OF TREATING HIV-1 INFECTION
#64Compounds for treating corona virus infection
#65INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#66PHARMACEUTICAL COMPOSITION AND USE THEREOF FOR RELIEVING PROGRESSION OF CHRONIC KIDNEY DISEASE OR PREVENTING THEREOF
#67SOTORASIB DOSING REGIMEN
#68MONOCYCLIC AGONISTS OF STIMULATOR OF INTERFERON GENES STING
#69NOVEL ANTIVIRAL THERAPIES
#70ETIFOXINE FOR USE IN THE TREATMENT OF DISEASES RELATED TO ACTIVATED MAST CELLS
#71METHODS OF TREATING SUBSTANCE ABUSE DISORDER, DYSPNEA, TINNITUS, AND CHILD AND ADOLESCENT DEPRESSION
#72Estrogen receptor mutations and uses thereof
#73METHODS OF TREATING SOLID TUMORS WITH CCR2 ANTAGONISTS
#74COMBINATION TREATMENT OF SPECIFIC FORMS OF EPILEPSY
#75HBV inhibitor and its use
#76METHODS FOR CONTROLLING PROSTAGLANDIN-MEDIATED BIOLOGICAL PROCESSES
#77Substituted tetrahydropyrans as CCR2 modulators
#78Pan-RAF kinase inhibitor and use thereof
#79METHODS FOR THE TREATMENT OF PERIMENOPAUSE AND MENOPAUSE
#80REVERSE TRANSCRIPTASE BLOCKING AGENTS AND METHODS OF USING THE SAME
#81Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
#82APPLICATION OF 2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES IN ANTIVIRAL THERAPY
#83TOPICAL USE OF LEVOFLOXACIN FOR REDUCING LUNG INFLAMMATION
#84Compounds, Compositions, and Methods for use in Treating Autophagy-Associated Disorders
#85Compositions and methods for enhanced delivery of antiviral agents
#86SELECTIVE GLUCOCORTICOID RECEPTOR MODIFIERS FOR TREATING IMPAIRED SKIN WOUND HEALING
#87ANTIVIRAL THERAPY
#88METHODS OF TREATING CENTRAL NERVOUS SYSTEM DISORDERS
#89Treatment of immunosuppressed subjects
#90ENDOGENOUS CYTOPLASMIC ALU COMPLEMENTARY DNA IN AGE-RELATED MACULAR DEGENERATION
#91COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF ANTIVIRAL AGENTS
#92Substituted imidazoles for preventing and/or treating cell or tissue necrosis
#93Phosphinic amide prodrugs of tenofovir
#94N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO
#95Anti-ErbB2 antibody-drug conjugate and composition thereof, preparation method therefor, and use thereof
#96SMALL MOLECULE IRE1-ALPHA INHIBITORS
#97Pharmaceutical composition for prevention or treatment of flavivirus infection
#98DRUG-LOADED TISSUE ADHESIVE FILM AND PREPARATION METHOD THEREFOR
#99Agonists of stimulator of interferon genes sting
#100Platform drug delivery system utilizing crystal engineering and theanine dissolution
#101Cellulose ether-lactam hybrid polymers, compositions, and methods for preparing and using the hybrid polymers
#102Treatment for Tau-Related Diseases
#103Methods and compositions for the treatment of tuberculosis
#104AEROSOL FLUOROQUINOLONE FORMULATIONS FOR IMPROVED PHARMACOKINETICS
#105Antiviral prodrugs and formulations thereof
#106Thalidomide analogs and methods of use
#107Deuterated analogs of etifoxine, their derivatives and uses thereof
#108Heterocyclic compounds
#109CENICRIVIROC FOR THE TREATMENT OF FIBROSIS
#110Antiviral JAK inhibitors useful in treating or preventing coronaviridae infections
#111Thalidomide analogs and methods of use
#112PARTICLES
#113STABLE FORMULATIONS FOR THE ORAL ADMINISTRATION OF AMPHOTERICIN B AND RELATED METHODS
#114Inhibitors of hepatitis C virus replication
#115Method of treating cancer and bone cancer pain
#116Antiviral therapy
#117Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
#118Compounds, compositions, and methods for use in treating autophagy-associated disorders
#119SMALL MOLECULE MODULATORS OF HUMAN STING
#120Histone acetyltransferase activators and uses thereof
#121Anti-retroviral treatment using growth hormone
#122BICYCLICALLY SUBSTITUTED URACILS AND THE USE THEREOF
#123METHODS AND COMPOSITIONS FOR TREATING PARKINSON'S DISEASE
#124Capsid inhibitors for the treatment of HIV
#125Chemical modulators of signaling pathways and therapeutic use
#126Molecular Composition for Enhancing and Rejuvenating Maintenance and Repair of Mammalian Tissues
#127Methods of treating developmental disorders and/or seizure disorders with etifoxine
#128Use of chymase inhibitors for the treatment of endometriosis, post operative fibrosis and diseases which are characterized by fibrosis formation
#129N-{[2-(piperidin-1-yl)phenyl](phenyl)methyl}-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)acetamide derivatives and related compounds as ROR-gamma modulators for treating autoimmune diseases
#130Multiple drug lipid nanoparticle composition and related methods for extended drug levels in blood and lymph tissue
#131INJECTION SOLUTION COMPRISING A NON-NUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR AND POLY(LACTIDE-CO-GLYCOLIDE)
#132Antiviral benzyl-amine phosphodiamide compounds
#133Aerosol fluoroquinolone formulations for improved pharmacokinetics
#134Substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptors
#135Antiviral aryl-amide phosphodiamide compounds
#136NOVEL ESTROGEN RECEPTOR MUTATIONS AND USES THEREOF
#137Methods of treating solid tumors with CCR2 antagonists
#138Therapeutic and method of use
#139K-RAS MUTATIONS AND ANTAGONISTS
#140Combination therapy using a chemokine receptor 2 (CCR2) antagonist and a PD-1/PD-L1 inhibitor
#141Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
#142INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#143CENICRIVIROC FOR THE TREATMENT OF FIBROSIS
#144Methods of treating developmental disorders and/or seizure disorders with etifoxine
#145ANTI-ERBB2 ANTIBODY-DRUG CONJUGATE AND COMPOSITION THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#146Piperidine derivative
#147Cosmetic composition and the use thereof for regulating skin quality
#148Small molecule IRE1-α inhibitors
#149TRPA1 modulators
#150Deuterated analogs of etifoxine, their derivatives and uses thereof
#151Histone Acetyltransferase Activators and Uses Thereof
#152COMBINATION TREATMENT OF SPECIFIC FORMS OF EPILEPSY
#153Estrogen receptor mutations and uses thereof
#154Injection solution comprising a non-nucleoside reverse-transcriptase inhibitor and poly(lactide-co-glycolide)
#155Substituted thiazoles for preventing and/or treating cell or tissue necrosis
#156AMPHIPHILIC POLYMERS ENCAPSULATING THERAPEUTICALLY ACTIVE AGENTS
#157Benzhydrol derivatives for the management of conditions related to hypoxia inducible factors
#158Thalidomide analogs and methods of use
#159Bicyclically substituted uracils and the use thereof
#160Pharmaceutical antiretroviral composition
#161ANTIVIRAL THERAPY
#162ANTI-RETROVIRAL TREATMENT USING GROWTH HORMONE
#163Thienopyridine derivative for the treatment of hepatitis C infections
#164Aerosol fluoroquinolone formulations for improved pharmacokinetics
#165ANTIVIRAL THERAPY
#166Antiviral compositions
#167Substituted tetrahydropyrans as CCR2 modulators
#168Topical use of levofloxacin for reducing lung inflammation
#169Deuterated analogs of etifoxine, their derivatives and uses thereof
#170PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION
#171Nanoemulsions
#172Hepatitis B antiviral agents
#173Mitochondrial uncouplers for treatment of metabolic diseases and cancer
#174Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
#175ANTIVIRAL THERAPY
#176Benzoxazinone derivatives for treatment of skin diseases
#177Small molecule IRE1-α inhibitors
#178Molecular composition for enhancing and rejuvenating maintenance and repair of mammalian tissues
#179Materials and methods for targeting therapeutic compositions to gut-associated lymphoid tissue (GALT)
#180Particles containing branched polymers
#181HISTONE ACETYLTRANSFERASE ACTIVATORS AND USES THEREOF
#182Compositions and Methods for Increasing the Suppression of Hunger and Reducing the Digestibility of Non-Fat Energy Satiety
#183Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
#184Antiviral therapy
#185COMBINATION TREATMENT OF SPECIFIC FORMS OF EPILEPSY
#186Therapy for constipation
#187Bicyclically substituted uracils and the use thereof
#188Bicyclically substituted uracils and the use thereof
#189Benzoxazinone derivatives for treatment of skin diseases
#190TRPA1 modulators
#191Treatment of degenerations and light-induced damage to the retina
#192Substituted tetrahydropyrans as CCR2 modulators
#193Aerosol fluoroquinolone formulations for improved pharmacokinetics
#194INHIBITORS OF LONG AND VERY LONG CHAIN FATTY ACID METABOLISM AS BROAD SPECTRUM ANTI-VIRALS
#195Platform drug delivery system utilizing crystal engineering and theanine dissolution
#196Platform drug delivery system utilizing crystal engineering and theanine dissolution
#197Platform drug delivery system utilizing crystal engineering and theanine dissolution
#198Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
#199Antiviral compounds
#200NEW BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF
#201Fusion proteins and methods for treating HIV infection and AIDS related symptoms
#202Estrogen receptor mutations and uses thereof
#203Combination of Kinase Inhibitors and Uses Thereof
#204CENICRIVIROC COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
#205Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
#206Therapeutic and method of use
#207Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
#208Antiviral compositions
#209Schedules for administering combination therapies useful for treating persons afflicted with the human immunodeficiency virus (HIV)
#210Increased dosage of efavirenz for the treatment of cancer
#211Compositions and methods for increasing the suppression of hunger and reducing the digestibility of non-fat energy satiety
#212QUADRUPLE THERAPY USEFUL FOR TREATING PERSONS AFFLICTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS (HIV)
#213Lipase inhibitors for the treatment of pancreatitis and organ failure
#214Hormone Normalization Therapy and Uses Therefor
#215Hepatitis B antiviral agents
#216NOVEL POWDERED CRYSTALLINE MEDICINES FOR INHALATION
#217ANTIVIRAL TREATMENT OF LYMPHOMA AND CANCER
#218THERAPY FOR CONSTIPATION
#219Pharmaceutical antiretroviral composition
#220N-(3-heteroarylaryl)-4-arylarylcarboxamides and analogs as hedgehog pathway inhibitors and use thereof
#221Polymeric nanoparticles in a thermosensitive gel for coital-independent vaginal prophylaxis of HIV
#222Unitary pharmaceutical dosage form
#223Hepatitis B antiviral agents
#224Pharmaceutical compositions of anti-viral compounds and process for preparation thereof
#225NOVEL BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF
#226Methods And Compositions For Reducing Pain, Inflammation, And/Or Immunological Reactions Associated With Parenterally Administering A Primary Therapeutic Agent
#227CELLULOSE DERIVATIVES FOR INHIBITING CRYSTALLIZATION OF POORLY WATER-SOLUBLE DRUGS
#228Compositions and methods of treating HIV-1 infections using same
#229Combination Therapy
#230Therapeutic and method of use
#231Pharmaceutical composition for treating diabetes
#232Aerosol fluoroquinolone formulations for improved pharmacokinetics
#233MICRONIZED TANAPROGET, COMPOSITIONS, AND METHODS OF PREPARING THE SAME
#234Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
#235PROTEIN-POLYSACCHARIDE CONJUGATES AND USE FOR ENCAPSULATING NUTRACEUTICALS FOR CLEAR BEVERAGE APPLICATIONS
#236Catechol diethers as potent anti-HIV agents
#237Methods, pharmaceutical compositions and kits for use in the treatment of adult T-cell leukemia/lymphoma
#238Dietary supplements including glucan and fulvic acid
#239Mixed lineage kinase inhibitors and method of treatments
#240Compositions of efavirenz
#241Substituted 4-(1H-pyrazol-4-yl)benzyl analogues as positive allosteric modulators of mAChR Mreceptors
#242Tanaproget Compositions Containing Ethinyl Estradiol
#243Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia
#244Hepatitis B antiviral agents
#245SOLID PREPARATION
#246Hepatitis B antiviral agents
#247COMPOSITIONS FOR AMELIORATING SYSTEMIC INFLAMMATION AND METHODS FOR MAKING AND USING THEM
#248Pharmacophores for Amyloid Fibers Involved in Alzheimer's Disease
#249Highly loaded amorphous efavirenz composition and process for preparing the same
#250Heteroaryl derivatives and uses thereof
#251Hepsin inhibitors
#252Therapy for Constipation
#253Cyclic Progestin Regimens and Kits
#254Unitary pharmaceutical dosage form
#255Oxidosqualene cyclase as a protein target for anticancer therapeutics
#256Micronized Tanaproget and Compositions Containing Same
#257Pharmaceutical Composition
#258Matrix metalloproteinase inhibitors
#259Pharmaceutical composition of salicylanilide-derived small molecules and preparation and application thereof
#260Cyclothiocarbamate derivatives as progesterone receptor modulators
#261Compositions and Methods for the Delivery of Therapeutics
#262Inhibitors of long and very long chain fatty acid metabolism as broad spectrum anti-virals
#263Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C
#264Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
#265NOVEL HIV REVERSE TRANSCRIPTASE INHIBITORS
#266NEW BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF
#267Relating to antiviral compositions
#268Methods, pharmaceutical compositions and kits for use in the treatment of adult T-cell leukemia/lymphoma
#269Compounds and assays for controlling Wnt activity
#270COMBINATION CANCER THERAPY WITH HERV INHIBITION
#271Antiviral Therapy
#272Lipase inhibitors for the treatment of pancreatitis and organ failure
#273PROTEIN-POLYSACCHARIDE CONJUGATES AND USE FOR ENCAPSULATING NUTRACEUTICALS FOR CLEAR BEVERAGE APPLICATIONS
#274Schedules for administering combination therapies useful for treating persons afflicted with the human immunodeficiency virus (HIV)
#275Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases
#276Quadruple therapy useful for treating persons afflicted with the human immunodeficiency virus (HIV)
#2774-AMINO-1,3-THIAZINE OR OXAZINE DERIVATIVE
#278Process for preparing efavirenz polymorph
#279Bioequivalent formulation of efavirenz
#280Derivatives of N-hydroxybenzamide for treating HIV infections
#281NOVEL POWDERED CRYSTALLINE MEDICINES FOR INHALATION
#282ANTIVIRAL TREATMENT OF LYMPHOMA AND CANCER
#283ACTIVE SUBSTANCE COMBINATION COMPRISING A COMPOUND WITH NPY RECEPTOR AFFINITY AND A COMPOUND WITH 5-HT6 RECEPTOR AFFINITY
#284Tanaproget compositions containing ethinyl estradiol
#285Crystal of a benzoxazinone compound
#2867-nitro-2-(3-nitro phenyl)-4H-3,1-benzoxazin-4-one or derivatives thereof for treating or preventing antiviral infections
#287Method of treating cancer by inhibition of protein kinase-like endoplasmic reticulum protein kinase
#288WET GRANULATION OF TENOFOVIR, EMTRICITABINE AND EFAVIRENZ
#289COMPOSITIONS AND METHODS FOR TREATING VISUAL DISORDERS
#290Nanoparticles and methods of use
#291Heterocyclic antiviral compounds
#292AEROSOL FORMULATIONS FOR THE INHALATION OF BETA-AGONISTS
#293Hepsin inhibitors
#294Micronized tanaproget and compositions containing same
#295Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
#296Pyrimidine derivatives as HIV reverse transcriptase inhibitors
#297Methods of Using SAHA for Treating HIV Infection
#298Compounds and assays for controlling Wnt activity
#299Cyclic progestin regimens and kits
#300Compositions and methods for increasing the suppression of hunger and reducing the digestibility of non-fat energy satiety